Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
Clinical trial NCT05195112 · COMPLETED
Trial details
- NCT number
- NCT05195112
- Sponsor
- Medy-Tox
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-24
- Primary completion
- 2023-02-18
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.